Sustained MRD‐Negative Complete Remission of T‐PLL With CNS Involvement Following Treatment With Systemic and Intrathecal Alemtuzumab
eJHaem · 2026-12 · 7 (6)
DOI: 10.1002/jha2.70456 ↗Kurz gefasst
Fachartikel in der Zeitschrift eJHaem, online erschienen am 11.11.2026. Verfasst von Isobel Rowe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology Royal North Shore Hospital Sydney Australia. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
T‐cell prolymphocytic leukaemia (T‐PLL) with central nervous system (CNS) involvement is uncommon and evidence guiding its treatment is limited. Case summary We describe the successful treatment of T‐PLL with leptomeningeal involvement using intrathecal alemtuzumab followed by allogeneic haematopoietic stem cell transplantation. Residual disease monitoring of T‐cell receptor clonotypes by next‐generation sequencing was performed to assess treatment response and guide post‐SCT intervention. At 24 months post‐SCT, the patient remains in sustained molecular remission.
Conclusion
This case adds to the limited literature supporting activity of intrathecal alemtuzumab in refractory CNS disease and highlights the utility of molecular monitoring following SCT. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Haematology Royal North Shore Hospital Sydney Australia.
- Faculty of Health and Medicine The University of Sydney Sydney Australia.
- Department of Pharmacy Royal North Shore Hospital Sydney Australia.
- New South Wales Health Pathology Royal North Shore Hospital Sydney Australia.
Zitieren
APA
Rowe, I., Jeffrey, A. D., McCauley, A., Lee, L., Leyton, A., Kunverji, K., Kumar, P., & Greenwood, M. (2026). Sustained MRD‐Negative Complete Remission of T‐PLL With CNS Involvement Following Treatment With Systemic and Intrathecal Alemtuzumab. eJHaem, 7(6). https://doi.org/10.1002/jha2.70456
Vancouver
Rowe I, Jeffrey AD, McCauley A, Lee L, Leyton A, Kunverji K, et al. Sustained MRD‐Negative Complete Remission of T‐PLL With CNS Involvement Following Treatment With Systemic and Intrathecal Alemtuzumab. eJHaem. 2026;7(6). doi:10.1002/jha2.70456
BibTeX
@article{Rowe2026,
author = {Rowe, Isobel and Jeffrey, Anthony D and McCauley, Ariana and Lee, Linda and Leyton, Arda and Kunverji, Khilna and Kumar, Poomahal and Greenwood, Matthew},
title = {Sustained MRD‐Negative Complete Remission of T‐PLL With CNS Involvement Following Treatment With Systemic and Intrathecal Alemtuzumab},
journal = {eJHaem},
year = {2026},
volume = {7},
number = {6},
doi = {10.1002/jha2.70456}
}
EUVIMED